arXiv:2606. 19092v1 Announce Type: cross Abstract: Chronic disease management relies on regular patient-provider interactions to follow-up on disease progression and control.
By Parisa Lotfibagha, Kristen Miller, William J. Gallagher, Elizabeth B. Selden, Muge Capan
arXiv:2608. 19501v1 Announce Type: cross Abstract: Diagnostic medical tests and devices provide useful information for evaluating the potential benefits and risks of therapeutic treatments.
By Wenxin Zhang, Rachael Phillips, Mark van der Laan
arXiv:2608. 19383v1 Announce Type: cross Abstract: Average dose-response functions are widely used to summarize causal effects of continuous treatments, but most existing methods assume that the observed sample represents the target population.
By Jay Jojo Cheng, Guanhua Chen
The paper introduces a new algorithm that uses decision trees and random forests to estimate individual treatment effects while providing interpretability. It modifies the standard random forest splitting criterion by combining a heterogeneity-focused criterion with a bias-correction criterion, enabling the model to handle observational studies with varying treatment propensities without separately estimating propensity scores. The resulting tree structure directly reveals which features drive treatment effect differences, and simulation studies show the method matches or surpasses existing approaches in prediction accuracy while improving interpretability.
By Nicolas Alexander Ihlo, Merle Behr
arXiv:2605. 13430v3 Announce Type: replace-cross Abstract: Selection bias is pervasive in observational studies.
By Yiwen Qiu, Filip Kova\v{c}evi\'c, Shimeng Huang, Peter Spirtes, Francesco Locatello
arXiv:2604. 16763v3 Announce Type: replace Abstract: Causal inference from electronic health records (EHR) is fundamentally limited by unmeasured confounding: critical clinical states such as frailty, goals of care, and mental status are documented in free-text notes but absent from structured data.
By Lei Liu, Jialin Chen, Kathy Macropol
arXiv:2606. 08305v1 Announce Type: cross Abstract: Externally controlled survival trials are increasingly used when concurrent randomized controls are infeasible, particularly in oncology and rare-disease settings with time-to-event endpoints.
By Se Yoon Lee, Yonghyun Kwon, Jae Kwang Kim
arXiv:2609.06294v1 Announce Type: new
Abstract: Estimating conditional average treatment effects (CATE) enables efficient targeting of interventions, but many applications have limited experimental s...
By Maitreyi Swaroop, Shikha Bhat, Samantha Rodriguez, Tamar Krishnamurti, Bryan Wilder
arXiv:2606. 30702v1 Announce Type: cross Abstract: Structured tabular data dominates clinical medicine, yet existing benchmarks fail to reflect real-world properties like complex survey sampling, demographic oversampling, and subgroup fairness.
By Federico Felizzi
arXiv:2503. 20546v2 Announce Type: replace-cross Abstract: We consider the problem of estimating the expected causal effect $E[Y|do(X)]$ for a target variable $Y$ when treatment $X$ is set by intervention, focusing on continuous random variables.
By Marlies Hafer, Alexander Marx
arXiv:2609.22383v1 Announce Type: cross
Abstract: Instrumental variable (IV) methods address treatment endogeneity, but with non-compliance and heterogeneous treatment effects a binary instrument gen...
By Zixuan Yao, Guosheng Yin
The paper introduces a method for learning risk scores that remain reliable even when historical data contain unobserved confounders. By treating propensity weights as uncertain and applying sensitivity analysis with Wasserstein distributionally robust optimization, the authors formulate a robust learning problem solvable via an exponential cone program. Experiments on semi‑synthetic UCI data show the approach improves calibration by up to 29.2% over traditional benchmarks and 11.1% over the state of the art, without harming other performance metrics.
By Ryan Edmonds, Yingxiao Ye, Sina Aghaei, Andr\'es G\'omez, \c{C}a\u{g}{\i}l Ko\c{c}yi\u{g}it, Phebe Vayanos